Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03554278 · ClinicalTrials.gov registry record
Alteration of Stool Microbiota in Preterm Infants With Anemia
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT03554278: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT03554278 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03554278 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
This study evaluates the relationship between anemia and stool microbiota in premature infants. It also evaluates the relationship between blood transfusion and stool microbiota.
Primary Outcome
Quantify major bacterial groups, including Proteobacteria, Firmicutes, and Bacteroides in stool samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2018-10-09 |
| Est. Completion | 2023-10-30 |
What the finished NCT03554278 record still lists
NCT03554278 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03554278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03554278 about?
NCT03554278 is a clinical study titled "Alteration of Stool Microbiota in Preterm Infants With Anemia". This study evaluates the relationship between anemia and stool microbiota in premature infants. It also evaluates the relationship between blood transfusion and stool microbiota.
What is the current status of trial NCT03554278?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2018-10-09. Estimated completion is 2023-10-30.
Who is sponsoring clinical trial NCT03554278?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI